Hear from DIA Europe participants
Hans-Jörg Römming, Executive Director, Head of Global Patient Safety Operations, Merck Healthcare KGaA"Our industry is changing fundamentally with the new digital possibilities and we are all going through transformative processes. DIA Europe 2021 was an excellent forum to exchange on technologies and progress and to share best practices."
Hubert Leufkens, Professor, Pharmaceutical Policy and Regulatory Science, Utrecht University"In preparing the various sessions, I was impressed by the fruitful, very constructive, interactions between the program committee, speakers, moderators, DIA colleagues, colleagues from pharma, EMA, NCAs, academia, patients, etc."
Mireille Muller, Regulatory Policy & Intelligence Director, Novartis Pharma AG"Many thanks to you: you managed this meeting beautifully – the sessions were handled very professionally. The content was interesting. The end-user experience was much more pleasant than last year…although personally I can’t wait the return of the live event in Brussels next year."
Tina Barton, Chief Operating Officer, Emerging Markets Quality Trials (EMQT)"Being a part of DIA Europe was even more important than ever this year not only because of COVID 19 but also because the current climate calls out for innovation and out-of-the-box thinking. eMQT in collaboration with our technology partners, JE Consulting were impressed with the seamless organisation, the relevance of the topics and calibre of presented contents. A key highlight was the active engagement and interaction with the audience coupled with the quality of questions asked around our specific topic, highlighting the hunger for the use of technology in pharma industry as a way of increasing efficiency in operational delivery."